Skip to content
10-Q

Quarterly Report

Audentes Therapeutics, Inc.

0001628280-19-010206

← back to feed
Filed
Aug 7, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 1, 2019 45.44M sh
Capex Q2 2019 · Jun 30, 2019 $5.64M
Capex Q2 2019 · Jun 30, 2018 $5.37M
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$83.04M
Operating Cash Flow Q2 2019 · Jun 30, 2018 −$47.94M
Short Term Investments Q2 2019 · Jun 30, 2019 $279.64M
Short Term Investments Q2 2019 · Dec 31, 2018 $269.96M
Cash And Equivalents Q2 2019 · Jun 30, 2019 $99M
Cash And Equivalents Q2 2019 · Dec 31, 2018 $144.35M
Stockholders Equity Q2 2019 · Jun 30, 2019 $419.7M
Stockholders Equity Q2 2019 · Mar 31, 2019 $402M
Stockholders Equity Q2 2019 · Dec 31, 2018 $442.75M
Stockholders Equity Q2 2019 · Jun 30, 2018 $340.96M
Stockholders Equity Q2 2019 · Mar 31, 2018 $352.44M
Stockholders Equity Q2 2019 · Dec 31, 2017 $156.6M
Current Liabilities Q2 2019 · Jun 30, 2019 $27.33M
Current Liabilities Q2 2019 · Dec 31, 2018 $23.85M
Total Liabilities Q2 2019 · Jun 30, 2019 $58.41M
Total Liabilities Q2 2019 · Dec 31, 2018 $29.8M
Current Assets Q2 2019 · Jun 30, 2019 $392.84M
Current Assets Q2 2019 · Dec 31, 2018 $419.77M
Total Assets Q2 2019 · Jun 30, 2019 $478.11M
Total Assets Q2 2019 · Dec 31, 2018 $472.56M
Sga Expense Q2 2019 · Jun 30, 2019 $9.78M
Sga Expense Q2 2019 · Jun 30, 2019 $21.77M
Sga Expense Q2 2019 · Jun 30, 2018 $6.28M
Sga Expense Q2 2019 · Jun 30, 2018 $12.8M
Rd Expense Q2 2019 · Jun 30, 2019 $37.3M
Rd Expense Q2 2019 · Jun 30, 2019 $77.14M
Rd Expense Q2 2019 · Jun 30, 2018 $26.35M
Rd Expense Q2 2019 · Jun 30, 2018 $46.24M
Net Income Q2 2019 · Jun 30, 2019 −$44.76M
Net Income Q2 2019 · Jun 30, 2019 −$94.16M
Net Income Q2 2019 · Mar 31, 2019 −$49.39M
Net Income Q2 2019 · Jun 30, 2018 −$31.37M
Net Income Q2 2019 · Jun 30, 2018 −$56.94M
Net Income Q2 2019 · Mar 31, 2018 −$25.57M
Operating Income Q2 2019 · Jun 30, 2019 −$47.08M
Operating Income Q2 2019 · Jun 30, 2019 −$98.91M
Operating Income Q2 2019 · Jun 30, 2018 −$32.63M
Operating Income Q2 2019 · Jun 30, 2018 −$59.04M